-63% reduction from baseline at 52 weeks
3 patients still to complete 12 month trial in Q3
positive news
- Forums
- ASX - By Stock
- SNT
- Ann: New positive interim data in Phase 2 study of SNT-5505
SNT
syntara limited
Add to My Watchlist
13.4%
!
5.8¢

Ann: New positive interim data in Phase 2 study of SNT-5505, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.8¢ |
Change
-0.009(13.4%) |
Mkt cap ! $100.7M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 5.7¢ | $304.2K | 4.993M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 62784 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 38889 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 62895 | 0.058 |
5 | 392284 | 0.057 |
3 | 450000 | 0.056 |
4 | 621819 | 0.055 |
3 | 39545 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 38889 | 4 |
0.061 | 158355 | 2 |
0.062 | 63827 | 2 |
0.064 | 48000 | 1 |
0.065 | 209602 | 4 |
Last trade - 12.39pm 16/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |